Advanced esophageal cancer with tracheobronchial fistula successfully treated by　esophageal bypass surgery  by Kimura, Masahiro et al.
CASE REPORT – OPEN ACCESS
International Journal of Surgery Case Reports 9 (2015) 115–118
Contents lists available at ScienceDirect
International Journal of Surgery Case Reports
journa l homepage: www.caserepor ts .com
Advanced esophageal cancer with tracheobronchial ﬁstula
successfully treated by esophageal bypass surgery
Masahiro Kimura ∗, Hideyuki Ishiguro, Tatsuya Tanaka, Hiromitsu Takeyama
Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
a r t i c l e i n f o
Article history:
Received 6 January 2015
Received in revised form 28 February 2015
Accepted 28 February 2015
Available online 4 March 2015
Keywords:
Bronchoesophageal ﬁstula
Bypass surgery
Esophageal cancer
a b s t r a c t
INTRODUCTION: When esophageal cancer inﬁltrates the respiratory tract and forms a ﬁstula, a patient’s
quality of life falls remarkably. Abstinence from oral feeding is necessary to prevent respiratory compli-
cations including pneumonia. Surgery is sometimes necessary to maintain quality of life. The aim of this
study was to examine clinical outcomes of esophageal cancer complicated by tracheobronchial ﬁstula.
PRESENTATION OF CASE: Twelve patients who underwent esophageal bypass between 2006 and 2011 in
our hospital were studied. Patient characteristics, therapeutic course, outcome, and operation type were
compared. Six patients among 8who could not tolerate oral feeding could do so after bypass surgery. Ten
patients were able to enjoy oral intake up until the last few days of life. Three patients survived for more
than 10 months. In spite of undergoing an operation, 1 patient survived for only 2 months and another
for 4 months. The only complication was postoperative delirium in 1 patient.
DISCUSSION:While surgical bypass ismore invasive than procedures such as endoscopic stenting, we had
few complications after operative intervention and were able to maintain quality of life in our patients.
CONCLUSION: This bypass procedure is a treatment option for patientswith tracheobronchial ﬁstula from
advanced esophageal cancer.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Since both the esophagus and trachea are organs of foregut ori-
gin, the thoracic esophagus is in contact with the trachea through
much of its course in the thoracic cavity. Due to this close anatom-
ical spatial relationship, advanced esophageal cancer can directly
invade into the respiratory tract. As the ability to tolerate oral feed-
ing is compromised in many patients with advanced esophageal
cancer, the quality of life (QOL) in these patients is often times
markedly reduced.
Treatment of tracheobronchial ﬁstula includes both endoscopic
stent therapy and surgical bypass [1,2]. Stent therapy, which has
in recent years become a more widely used modality, includes
placement of a covered, self-expanding metallic stent overlying
the ﬁstulous connection [3,4]. This modality is minimally invasive,
effective, and can lead to ﬁstula closure. Stents are not effective,
however, in cases in which the tumor inﬁltrates the lung. On
the other hand, surgical bypass, while invasive, may allow for
administration of postoperative chemoradiation, thus increasing
long-term survival. We herein report 12 patients with respiratory
tract ﬁstulae successfully treated by esophageal bypass surgery.
∗ Corresponding author. Tel.: +81 52 853 8226; fax: +81 52 842 3906.
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1.1. Patients
Twelve patients who underwent esophageal bypass between
2006 and 2011 at Nagoya City University were studied. All patients
had squamous cell carcinoma. Therewere 8men and 4women and
the mean age was 65.8 years (range, 50–78 years). The majority of
tumors were located the middle third of the esophagus (Table 1).
There were 5 cases in which only the lung was inﬁltrated, 3 cases
involving only the bronchus, and 4 cases involving both the lung
and the bronchus.
1.2. Operation
Five cases were started via a right thoracotomy for the pur-
pose of esophagectomy but converted to a bypass procedure. Seven
cases were approached as bypass operations from the beginning.
Mean operative time was 327min and mean blood loss was 286g
(Table 2).
2. Methods
An upper midline abdominal incision was made and a Kocher
maneuver performed. At a safe distance from the right gastroepi-
ploic artery and vein, the omentum was divided. As the spleen was
approached, the left gastroepiploic vessels were carefully ligated,
and the short gastric vessels were divided.
http://dx.doi.org/10.1016/j.ijscr.2015.02.053
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1
Clinical characteristics of the studied group.
Clinical characteristics
Gender
Male 8
Female 4
Age, mean (range) 65.8(50–78)
Main tumor site
Upper third 2
Middle third 9
Lower third 1
PNI, mean (range) 37.2(29.5–48)
Table 2
Operation and complications.
Variable Outcome
Operative time, median (range) 327(237–433)min
Blood loss, median (range) 286(83–553) g
Thoracotomy, n (%) 5(42)
Postoperative complications, n (%)
Delirium 1(8.7)
30-day mortality, n (%) 0(0)
We transﬁxed the entirewall of the stomach to the antrum5cm
from the pylorus using a 21-mm intraluminal stapler, creating a
ring surrounded with staples. Next, we created a tube which mea-
sured 3 cm in diameter using a linear stapler. Four to six staple
applicationswere needed. The part corresponding to the lesser cur-
vature serves to drain the distal esophagus in relation to the tumor,
and the greater curvature makes up the tube.
A neck incision, 10–12 cm long, was made along the inner bor-
der of the sternocleidomastoid muscle. The platysma muscle was
divided. After dissection and division of the cervical esophagus, the
distal end was amputated using a linear stapler. A pursestring was
fashioned for positioning the head of a 25-mm intraluminal stapler
in the stump of the proximal esophagus.
After the subcutaneous tunnel was formed, the gastric tube end
was brought into the neck.We then proceededwith the anastomo-
sis of the proximal stump of the cervical esophagus to the proximal
end of the terminolateral gastric tube using a 25-mm intralumi-
nal stapler. The excess tubing was sectioned using a linear stapler.
Recently, the method of starting separation from cardia of having
improved the Postlethwait method is performed [5].
2.1. Postoperative course
A nasogastric tube was kept in place for 5 days postoperatively.
If the patient was clinically stable, esophagographywas performed
on the seventh postoperative day, and oral feeding was started if
therewas no leak. Liquid dietwas initiated and advanced to regular
solid food by time of discharge.
3. Results
3.1. Pre-operative nutrient state
In eight of 12 cases, oral intakewas not tolerated preoperatively
because of esophageal stenosis or tracheobronchial ﬁstula (Fig. 1).
Nutrition was therefore poor in our patients and the mean value of
prognostic nutritional index (PNI) was 37.2. The mean PNI in the
patients who were not eating was 33.9 versus 43.8 in those who
were.
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Fig. 1. Change in the amount of meals before and after bypass operation.
Table 3
Chemoradiation therapy.
Variable
Chemotherapy
Low-dose CF(pre-operation) 4
Low-dose CF(post-operation) 4
Standard CF(pre-operation) 1
Standard CF(post-operation) 3
Radiotherapy
Pre-operation 5
Post-operation 5
3.2. Chemoradiation therapy
In all cases, chemotherapy was carried out before and/or after
the operation. Radiotherapy was performed in a total of 10 cases, 5
preoperatively and5postoperatively (Table3). Timingand strength
of radiation varied from case to case.
3.3. Postoperative complications and progress
Postoperative delirium occurred in 1 case. Anastomotic leak
occurred in 1 case. Transition to oral feeding was not possible in
2 cases, while the remaining 10 enjoyed oral intake until their last
days. In one case, pneumonia worsened rapidly after the opera-
tion. In another case, the respiratory status worsened secondary to
rapidly inﬁltrating cancer.
Therewere 3 cases surviving beyond 10months. Despite under-
going operation, one patient survived for only 2 months and
another for 4 months. However, in most cases ability to tolerate
oral feeding improved, respiratory symptoms did not occur, and a
good quality of life was maintained.
Cases with survival of more than 10 months are described
below:
3.3.1. Case 1
A78-year-oldwomanwas admitted to our hospital complaining
of bloody stools. She underwent esophagoscopy andwasdiagnosed
with esophageal cancer. A type 1 tumor with 80% circumferential
loss of the esophageal wall was observed in the middle thoracic
esophagus. She tolerated food without emesis. Computed tomog-
raphy revealed the tumor to abut the inferior pulmonary vein
and aorta, but nonetheless was deemed resectable and she under-
went right thoracotomy. Intraoperatively, the tumor was noted
to invade the lower lobe of the right lung and thus was deemed
unresectable. We elected to perform bypass surgery. Postopera-
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tively the patient convalesced well and adjuvant chemotherapy
(cisplatin +ﬂuorouracil:CF) was initiated. Radiotherapy was not
performed given her advanced age. She had no respiratory symp-
toms and died 11 months after the bypass.
3.3.2. Case 2
A 66-year-old woman was admitted to our hospital complain-
ing of inability to tolerate food, throat pain, cough, and hoarseness.
Esophagoscopy revealeda type2 tumor in themiddlepart of esoph-
agus, and the lesion was unable to be traversed with the camera.
Bronchoscopy revealed invasion of the tumor into the left main
bronchus with a ﬁstula. She spiked fever of 39 ◦C preoperatively.
Bypass surgery was thus performed. She defervesced on the third
postoperative day, and tolerated food one week after surgery. She
didwell for 12monthswith adjuvant therapy, after which time she
succumbed to pneumonia.
3.3.3. Case 3
A 78-year-old man was admitted to our hospital complaining
of hematemesis. Esophagoscopy revealed esophageal cancer. He
couldnot tolerate solidswhile in thehospital.Wedeemed resection
possible and performed a thoracotomy. It was noted intraopera-
tively that the tumor had invaded the lower lobe of the right lung
and the left mainstem bronchus, making the tumor unresectable.
Bypass surgery was performed. He convalesced well and toler-
ated food on the 8th postoperative day, and was discharged on the
17th postoperative day. One month after discharge, he underwent
59.4Gy of radiotherapy in addition to chemotherapy. He died from
massive hemoptysis 17 months after his bypass surgery.
4. Discussion
It has been reported that esophago-respiratory tract ﬁstu-
lae occur in 5–15% of esophageal cancers [6]. In an advanced
esophageal cancer complicated by a ﬁstula, chemoradiation is the
primary treatment modality. However, esophageal cancer that
forms a tracheobronchial ﬁstula can lead to inability to tolerate
oral feeding as well as respiratory symptoms and pneumonia, all of
which markedly decrease a patient’s quality of life. These patients
are generally quite ill and have a poor prognosis.
Degree of invasion, efﬁcacy of medical treatment, prognosis,
and the general condition of the patient must all be considered
when weighing surgery as an option. Stents are now commonly
employed in cases of esophageal cancer complicated by respira-
tory tract ﬁstulae, with many patients able to resume oral feedings
within a few days after stent placement [7]. Complications of
stents include incomplete covering of the ﬁstula, stent migration,
and perforation of the esophagus after chemoradiation. The latter
case creates a situation in which chemoradiation must be prema-
turely stopped. Finally, ﬁstulae involving the lung cannot be treated
with stents. Another option for advanced esophageal cancer with
tracheobronchial ﬁstula is percutaneous endoscopic gastrostomy
(PEG). Advantages of PEG are the thing which can be made easily
and a thing capable of nutritional management. But since putting
it for the patient with esophago-respiratory tract ﬁstulae, a possi-
bility which causes aspiration pneumonia is high. It’s irreplaceable
delight to take orally. When limiting a patient, bypass surgery is
the most suitable way.
Therefore,wesometimeselect toperformbypass surgery,which
separates the passage of food and the respiratory tract. This is
clearly more invasive compared with stent treatment. In some
cases, invasion into the lung became clear only after carrying out
the thoracotomy, forcing an intraoperative shift to bypass surgery.
Regarding other surgical options, tube esophagostomy can
achieve external esophageal drainage [8]. Alternatively, we have
chosen themethodwhich Postlethwait devised, the utility ofwhich
includes the fact that it does not lead to complications including
leakage. The problem with medical treatment is that, unless it is
dramatically successful, once complications occur in a patient with
an already dismal prognosis, quality of life rapidly declines,making
an operation unfeasible.
Critical to the bypass operation is a gastric tube with sufﬁcient
blood ﬂow and a technically sound esophago-gastric tube anasto-
mosis. For this reason, the surgeonmust bemindful of the width of
the gastric tube. If a gastric tube is too thin or too long, the blood
ﬂow to the gastric wall will be insufﬁcient, leading to necrosis and
failure of the sutures. While variable depending on the individual
shape of the stomach, the width of the gastric tube should be at
least 3 cm, enlarging to around 4 cm moving towards the left gas-
troepiploic artery domain. Anastomosis of the esophagus is carried
out to the back wall of the gastric tube.We have had no leaks using
thismethod. Regarding the reconstruction route, the subcutaneous
route is preferred inorder that, should a leakoccur, it doesnot cause
as seriousa systemic illness as itwouldhad the leakoccurredwithin
the thoracic cavity.
In patients with prolonged pneumonia before an operation,
inﬂammation often improves within a few days postoperatively.
Oral feeding is typically started on the 7th day after the operation.
Upon discharge, pending the patient’s overall general condition,
chemoradiation therapy is performed to improve prognosis, which
in our series exceeded 10 months in some patients [9,10]. This
bypass procedure is therefore considered to be a feasible treatment
choice for patients with respiratory tract ﬁstula.
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